NIH Scientists Banned from Studying Human Fetal Tissue

External researchers funded by US federal grants can continue their experiments under tighter scrutiny.

Written byKerry Grens
| 2 min read
esc embryonic stem cell fetal tissue

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, DRA_SCHWARTZ

The US Department of Health and Human Services announced yesterday (June 5) that scientists at the National Institutes of Health will no longer be able to study human fetal tissue, although projects funded by the US government at external institutions can continue with increased ethical oversight.

An anonymous senior official in President Donald Trump’s administration tells the Associated Press that the decision was Trump’s. “Promoting the dignity of human life from conception to natural death is one of the very top priorities of President Trump’s administration,” HHS’s statement reads.

Anti–abortion rights advocates praised the move, while a number of scientists expressed disappointment.

“Prohibiting valuable research that uses fetal tissue that is otherwise going to be discarded doesn’t make any sense,” Lawrence Goldstein, a regenerative medicine specialist at the University of California, San Diego, tells the AP. “It blocks important future research vital to the development of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies